SCHEMBL5178688

SCHEMBL5178688

CCC(C)N(C=O)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 6/20 0.42
GRIN2A Q12879 6/20 0.42
GRIN2D O15399 5/20 0.42
GRIN2C Q14957 5/20 0.42
GRIN2B Q13224 4/20 0.42
OPRM1 P35372 2/20 0.42
KCNH2 Q12809 2/20 0.42
CACNA1F O60840 1/20 0.42
ABCB1 P08183 1/20 0.42
CYP2B6 P20813 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
CACNA1D Q01668 1/20 0.42
CACNA1S Q13698 1/20 0.42
CACNA1C Q13936 1/20 0.42
MRGPRX2 Q96LB1 1/20 0.42
KCNN4 O15554 1/20 0.39
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11550667 0.69 ALDH1A1 (0.41) GRIN1GRIN2AGRIN2DGRIN2CGRIN2B
SCHEMBL271625 0.69
SCHEMBL1995341 0.67
SCHEMBL9130272 0.67 KCNN4 (0.56) OPRM1DRD4DRD3KCNN4ALDH1A1
SCHEMBL7317845 0.67 KCNN4 (0.41) GRIN1GRIN2AGRIN2DGRIN2CGRIN2B
Tert-Butylbenzene SCHEMBL10512662 0.64 GRIN1 (0.53) GRIN1GRIN2AGRIN2DGRIN2CGRIN2B
SCHEMBL28653244 0.64 KIF11 (0.41) GRIN1GRIN2AGRIN2DGRIN2CGRIN2B
SCHEMBL3087077 0.63 KIF11 (0.42) GRIN1GRIN2AGRIN2DGRIN2CGRIN2B
SCHEMBL27745335 0.63 KCNN4 (0.44) KCNN4ALDH1A1CYP2D6
SCHEMBL8660746 0.63 GRIN1 (0.54) GRIN1GRIN2AGRIN2DGRIN2CGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1811034-A2 Compounds and method for inhibiting axillary malodour Givaudan SA (CH) 2007-07-25 EP disclosed
EP-1387891-A2 COMPOUNDS AND METHODS FOR INHIBITING AXILLARY MALODOUR Givaudan SA (CH) 2004-02-11 EP disclosed
WO-2002092024-A2 COMPOUNDS AND METHODS FOR INHIBITING AXILLARY MALODOUR GIVAUDAN SA (CH) 2002-11-21 WO disclosed